Clinical Trial Update: Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rifaximin, loperamide, and their combination for traveler's diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traveler Diarrhea

Drugs mentioned

• Imodium (loperamide)
• XIFAXAN (rifaximin)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Travelers' Diarrhea | Phase 4 | Status: COMPLETED